Human Molecular Genetics Advance Access originally published online on May 23, 2009
Human Molecular Genetics 2009 18(16):3039-3047; doi:10.1093/hmg/ddp242
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset
1 Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA 2 Department of Biostatistics 3 Department of Neurology, Boston University School of Public Health, Boston, MA 02118, USA
* To whom correspondence should be addressed. Tel: +1 6176433103; Fax: +1 6176433203; Email: wheeler{at}helix.mgh.harvard.edu
Received March 26, 2009; Accepted May 19, 2009
The age of onset of Huntington's disease (HD) is determined primarily by the length of the HD CAG repeat mutation, but is also influenced by other modifying factors. Delineating these modifiers is a critical step towards developing validated therapeutic targets in HD patients. The HD CAG repeat is somatically unstable, undergoing progressive length increases over time, particularly in brain regions that are the targets of neurodegeneration. Here, we have explored the hypothesis that somatic instability of the HD CAG repeat is itself a modifier of disease. Using small-pool PCR, we quantified somatic instability in the cortex region of the brain from a cohort of HD individuals exhibiting phenotypic extremes of young and old disease onset as predicted by the length of their constitutive HD CAG repeat lengths. After accounting for constitutive repeat length, somatic instability was found to be a significant predictor of onset age, with larger repeat length gains associated with earlier disease onset. These data are consistent with the hypothesis that somatic HD CAG repeat length expansions in target tissues contribute to the HD pathogenic process, and support pursuing factors that modify somatic instability as viable therapeutic targets.